Total Payments
$14,400
2024 Payments
$1,676
Companies
43
Transactions
392
Medicare Patients
2,100
Medicare Billing
$82,779
Payment Breakdown by Category
Consulting$6,808 (47.3%)
Food & Beverage$6,381 (44.3%)
Other$1,200 (8.3%)
Education$11.71 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $6,808 | 1 | 47.3% |
| Food and Beverage | $6,381 | 388 | 44.3% |
| Honoraria | $1,200 | 2 | 8.3% |
| Education | $11.71 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Welch Allyn | $8,008 | 3 | $0 (2018) |
| Novo Nordisk Inc | $825.94 | 54 | $0 (2024) |
| Lilly USA, LLC | $825.05 | 59 | $0 (2024) |
| ABBVIE INC. | $604.97 | 40 | $0 (2024) |
| Astellas Pharma US Inc | $459.13 | 23 | $0 (2024) |
| Merck Sharp & Dohme LLC | $383.15 | 23 | $0 (2024) |
| PFIZER INC. | $355.20 | 24 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $321.42 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $276.06 | 13 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $273.55 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,676 | 84 | Lilly USA, LLC ($227.17) |
| 2023 | $757.22 | 42 | Novo Nordisk Inc ($162.72) |
| 2022 | $741.09 | 40 | ABBVIE INC. ($127.49) |
| 2021 | $863.01 | 59 | Lilly USA, LLC ($179.09) |
| 2020 | $645.13 | 41 | Lilly USA, LLC ($163.44) |
| 2019 | $837.56 | 58 | Novo Nordisk Inc ($154.16) |
| 2018 | $2,022 | 64 | Welch Allyn ($1,200) |
| 2017 | $6,859 | 4 | Welch Allyn ($6,808) |
All Payment Transactions
392 individual payment records from CMS Open Payments — Page 7 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/02/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: NEUROSCIENCE | ||||||
| 05/26/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Diabetes | ||||||
| 05/18/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Diabetes | ||||||
| 05/17/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: DIABETES | ||||||
| 04/21/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: NEUROSCIENCE | ||||||
| 04/06/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: NEUROSCIENCE | ||||||
| 03/30/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/26/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: NEUROSCIENCE | ||||||
| 03/17/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Diabetes | ||||||
| 02/17/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: NEUROSCIENCE | ||||||
| 02/05/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: NEUROSCIENCE | ||||||
| 01/27/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: RESPIRATORY | ||||||
| 01/21/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: NEUROSCIENCE | ||||||
| 01/20/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: NEUROSCIENCE | ||||||
| 01/13/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: VACCINES | ||||||
| 01/06/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.84 | General |
| 12/16/2021 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: VACCINES | ||||||
| 12/15/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.81 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2021 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $25.59 | General |
| Category: Allergy/Immunology | ||||||
| 12/01/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Diabetes | ||||||
| 11/18/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2021 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | Cash or cash equivalent | $15.63 | General |
| Category: Endocrinology | ||||||
| 11/02/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2021 | PFIZER INC. | PREVNAR 13 (Biological), TRUMENBA, PREVNAR 20 | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: VACCINES | ||||||
| 10/21/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.26 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,125 | 1,433 | $75,217 | $29,167 |
| 2022 | 18 | 386 | 606 | $51,560 | $22,513 |
| 2021 | 16 | 363 | 661 | $47,621 | $19,398 |
| 2020 | 12 | 226 | 377 | $29,222 | $11,701 |
Total Patients
2,100
Total Services
3,077
Medicare Billing
$82,779
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 115 | $21,965 | $9,632 | 43.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 109 | 131 | $8,384 | $3,771 | 45.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 176 | 223 | $2,230 | $1,873 | 84.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 117 | 142 | $7,526 | $1,824 | 24.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 23 | 23 | $1,909 | $1,654 | 86.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 11 | 11 | $2,640 | $1,392 | 52.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 25 | $3,250 | $1,249 | 38.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 62 | 74 | $3,478 | $1,218 | 35.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 102 | 111 | $7,104 | $1,125 | 15.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 121 | 147 | $3,381 | $1,111 | 32.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 66 | 81 | $2,511 | $752.08 | 30.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $1,000 | $737.75 | 73.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 44 | 48 | $2,064 | $702.13 | 34.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 38 | 63 | $2,898 | $513.98 | 17.7% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 25 | 25 | $1,325 | $473.00 | 35.7% |
| 84466 | Transferrin (iron binding protein) level | Office | 2023 | 14 | 20 | $560.00 | $250.00 | 44.6% |
| 84460 | Liver enzyme (sgpt), level | Office | 2023 | 24 | 43 | $602.00 | $223.17 | 37.1% |
| 84450 | Liver enzyme (sgot), level | Office | 2023 | 24 | 43 | $602.00 | $218.44 | 36.3% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 20 | 23 | $690.00 | $181.93 | 26.4% |
| 83540 | Iron level | Office | 2023 | 14 | 20 | $380.00 | $126.80 | 33.4% |
| 83735 | Magnesium level | Office | 2023 | 13 | 13 | $286.00 | $78.84 | 27.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 24 | 27 | $432.00 | $59.40 | 13.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 163 | $31,133 | $14,009 | 45.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 11 | 11 | $2,640 | $1,425 | 54.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 19 | 20 | $1,432 | $1,354 | 94.6% |
About Dr. Peer Soderberg, MD
Dr. Peer Soderberg, MD is a Family Medicine healthcare provider based in Elbridge, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316926397.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peer Soderberg, MD has received a total of $14,400 in payments from pharmaceutical and medical device companies, with $1,676 received in 2024. These payments were reported across 392 transactions from 43 companies. The most common payment nature is "Consulting Fee" ($6,808).
As a Medicare-enrolled provider, Soderberg has provided services to 2,100 Medicare beneficiaries, totaling 3,077 services with total Medicare billing of $82,779. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Elbridge, NY
- Active Since 01/10/2006
- Last Updated 05/12/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1316926397
Products in Payments
- Otoscope (Device) $1,200
- Ozempic (Drug) $307.86
- UBRELVY (Drug) $266.81
- MOUNJARO (Drug) $254.93
- EMGALITY (Drug) $216.54
- MYRBETRIQ (Drug) $213.29
- TRULICITY (Drug) $212.14
- VRAYLAR (Drug) $194.46
- Rybelsus (Drug) $193.95
- JARDIANCE (Drug) $192.24
- AIRSUPRA (Drug) $188.23
- TRINTELLIX (Drug) $181.92
- TRELEGY ELLIPTA (Drug) $180.60
- XIFAXAN (Drug) $153.28
- Veozah (Drug) $139.69
- Otezla (Drug) $131.17
- GARDASIL (Biological) $119.39
- VESICARE (Drug) $106.15
- QULIPTA (Drug) $105.59
- Tresiba (Drug) $105.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.